EP Patent

EP1871347B1 — Pharmaceutical composition

Assigned to Novartis AG · Expires 2016-08-03 · 10y expired

What this patent protects

Patent listed against lapatinib-ditosylate.

Drugs covered by this patent

lapatinib-ditosylate (LAPATINIB DITOSYLATE)

Patent Metadata

Patent number: EP1871347B1
Jurisdiction: EP
Classification: —
Expires: 2016-08-03
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.